Tadalista 60 mg contains tadalafil, a medication primarily used to treat erectile dysfunction (ED) by improving blood flow to the penis. It belongs to a group of medicines called PDE5 inhibitors. While tadalafil affects blood vessel function, it is not known to directly increase or decrease bone density.
Bone density is mainly influenced by factors such as age, hormones, genetics, physical activity, nutrition, and certain health conditions. Current medical evidence does not show that Tadalista 60 mg causes significant changes in bone mineral density. The medication is not designed to prevent or treat osteoporosis or other bone-related disorders.
Some studies have explored whether PDE5 inhibitors may have effects on bone health through blood flow and cellular pathways, but there is not enough evidence to confirm that tadalafil provides bone-strengthening benefits. Men concerned about bone health should focus on proven measures such as regular weight-bearing exercise, adequate calcium and vitamin D intake, and maintaining overall health.
If someone has osteoporosis risk factors, frequent fractures, or concerns about changes in bone strength while taking medications, they should consult a healthcare professional. A doctor can recommend appropriate evaluations and provide guidance based on individual health needs.
Tadalista 60 mg should be used only as directed, especially because higher doses may increase the chance of side effects.  |